Intuitive Surgical, Inc. (ISRG) EVP Sells $16,277,950.00 in Stock

Intuitive Surgical, Inc. (NASDAQ:ISRG) EVP David J. Rosa sold 32,500 shares of Intuitive Surgical stock in a transaction on Tuesday, October 23rd. The shares were sold at an average price of $500.86, for a total transaction of $16,277,950.00. Following the completion of the transaction, the executive vice president now owns 44,208 shares in the company, valued at $22,142,018.88. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink.

Intuitive Surgical stock opened at $486.89 on Friday. Intuitive Surgical, Inc. has a one year low of $359.75 and a one year high of $581.12. The firm has a market capitalization of $58.17 billion, a price-to-earnings ratio of 67.72, a price-to-earnings-growth ratio of 3.50 and a beta of 0.89.

Intuitive Surgical (NASDAQ:ISRG) last released its earnings results on Thursday, October 18th. The medical equipment provider reported $2.83 EPS for the quarter, beating analysts’ consensus estimates of $2.66 by $0.17. Intuitive Surgical had a return on equity of 18.79% and a net margin of 22.31%. The company had revenue of $920.90 million during the quarter, compared to the consensus estimate of $916.22 million. During the same quarter last year, the company earned $2.77 earnings per share. Intuitive Surgical’s quarterly revenue was up 14.0% compared to the same quarter last year. Equities research analysts expect that Intuitive Surgical, Inc. will post 9.35 EPS for the current year.



ISRG has been the topic of a number of analyst reports. Goldman Sachs Group lifted their price objective on shares of Intuitive Surgical from $540.00 to $630.00 and gave the company a “buy” rating in a research report on Friday, July 20th. Stifel Nicolaus raised their target price on Intuitive Surgical from $515.00 to $600.00 and gave the company a “buy” rating in a report on Friday, July 20th. Cantor Fitzgerald reissued a “buy” rating and issued a $620.00 target price (up previously from $510.00) on shares of Intuitive Surgical in a report on Friday, July 20th. Bank of America raised their target price on Intuitive Surgical from $510.00 to $600.00 and gave the company a “buy” rating in a report on Tuesday, July 17th. Finally, Citigroup raised their target price on Intuitive Surgical from $561.00 to $592.00 and gave the company a “buy” rating in a report on Thursday, August 2nd. One investment analyst has rated the stock with a sell rating, four have given a hold rating and seventeen have issued a buy rating to the company’s stock. The company presently has a consensus rating of “Buy” and a consensus target price of $554.01.

Several large investors have recently added to or reduced their stakes in ISRG. FMR LLC raised its stake in shares of Intuitive Surgical by 19.2% during the 2nd quarter. FMR LLC now owns 6,629,648 shares of the medical equipment provider’s stock worth $3,172,155,000 after buying an additional 1,068,107 shares during the last quarter. Morgan Stanley raised its stake in shares of Intuitive Surgical by 88.1% during the 2nd quarter. Morgan Stanley now owns 1,301,299 shares of the medical equipment provider’s stock worth $622,646,000 after buying an additional 609,465 shares during the last quarter. Summit Trail Advisors LLC raised its stake in shares of Intuitive Surgical by 49,853.2% during the 1st quarter. Summit Trail Advisors LLC now owns 215,798 shares of the medical equipment provider’s stock worth $216,000 after buying an additional 215,366 shares during the last quarter. Cornerstone Wealth Management LLC acquired a new position in shares of Intuitive Surgical during the 2nd quarter worth $341,000. Finally, Jennison Associates LLC raised its stake in shares of Intuitive Surgical by 5,005.3% during the 2nd quarter. Jennison Associates LLC now owns 158,825 shares of the medical equipment provider’s stock worth $75,995,000 after buying an additional 155,714 shares during the last quarter. 84.83% of the stock is owned by institutional investors and hedge funds.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc designs, manufactures, and markets da Vinci surgical systems, and related instruments and accessories. The company's da Vinci surgical System translates a surgeon's natural hand movements, which are performed on instrument controls at a console into corresponding micro-movements of instruments positioned inside the patient through small incisions or ports.

Further Reading: Is the Dow Jones Industrial Average (DJIA) still relevant?

Insider Buying and Selling by Quarter for Intuitive Surgical (NASDAQ:ISRG)

Receive News & Ratings for Intuitive Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intuitive Surgical and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply